Expression profiling and identification of novel genes in hepatocellular carcinomas

[1]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[2]  M. Buendia.  Genetics of hepatocellular carcinoma. , 2000, Seminars in cancer biology.

[3]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Abe,et al.  Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. , 1999, American journal of respiratory and critical care medicine.

[5]  K. Ogawa,et al.  Expression of an IL-1 receptor antagonist during mouse hepatocarcinogenesis demonstrated by differential display analysis. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[6]  P. Farnham,et al.  No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice , 1999, Molecular carcinogenesis.

[7]  M. C. Ling,et al.  Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells , 1999, Oncogene.

[8]  D. Adams,et al.  Expression and function of CXC and CC chemokines in human malignant liver tumors: A role for human monokine induced by γ‐interferon in lymphocyte recruitment to hepatocellular carcinoma , 1999, Hepatology.

[9]  Jacques Ferlay,et al.  Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.

[10]  J. F. Harris,et al.  Osteopontin expression in a group of lymph node negative breast cancer patients , 1998, International journal of cancer.

[11]  S. Nelson,et al.  Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization. , 1998, Nucleic acids research.

[12]  J Schultz,et al.  SMART, a simple modular architecture research tool: identification of signaling domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Yokozaki,et al.  Co‐expression of osteopontin and CD44v9 in gastric cancer , 1998, International journal of cancer.

[14]  A. Hochberg,et al.  Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. , 1998, Molecular pathology : MP.

[15]  S. Gill,et al.  Suppression of cytochrome P450 Cyp2f2 mRNA levels in mice by the peroxisome proliferator diethylhexylphthalate. , 1997, Biochemical and biophysical research communications.

[16]  P. Farnham,et al.  Strain‐dependent differences in DNA synthesis and gene expression in the regenerating livers of C57BL/6J and C3H/HeJ mice , 1995, Molecular carcinogenesis.

[17]  Peer Bork,et al.  SMART: a web-based tool for the study of genetically mobile domains , 2000, Nucleic Acids Res..

[18]  M. Kojiro,et al.  Histopathologic Evaluation of Hepatocellular Carcinoma with Special Reference to Small Early Stage Tumors , 1999, Seminars in liver disease.

[19]  D. Schatz,et al.  cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. , 1999, Methods in enzymology.

[20]  F. X. Bosch,et al.  Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.

[21]  M Hubank,et al.  Identifying differences in mRNA expression by representational difference analysis of cDNA. , 1994, Nucleic acids research.

[22]  P. Farnham,et al.  Erratum: A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter (Molecular and Cellular Biology 13:3 (1613)) , 1993 .

[23]  E. Farber.  THE PATHOLOGY OF EXPERIMENTAL LIVER CELL CANCER , 1976 .